{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:45:44Z","timestamp":1791996344287,"version":"4.4.0"},"reference-count":70,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:p>JOURNAL\/nrgr\/04.03\/01300535-202509000-00022\/figure1\/v\/2026-04-27T065306Z\/r\/image-tiff<\/jats:p>\n                  <jats:p>Poststroke cognitive impairment is a major secondary effect of ischemic stroke in many patients; however, few options are available for the early diagnosis and treatment of this condition. The aims of this study were to (1) determine the specific relationship between hypoxic and \u03b1-synuclein during the occur of poststroke cognitive impairment and (2) assess whether the serum phosphorylated \u03b1-synuclein level can be used as a biomarker for poststroke cognitive impairment. We found that the phosphorylated \u03b1-synuclein level was significantly increased and showed pathological aggregation around the cerebral infarct area in a mouse model of ischemic stroke. In addition, neuronal \u03b1-synuclein phosphorylation and aggregation were observed in the brain tissue of mice subjected to chronic hypoxia, suggesting that hypoxia is the underlying cause of \u03b1-synuclein-mediated pathology in the brains of mice with ischemic stroke. Serum phosphorylated \u03b1-synuclein levels in patients with ischemic stroke were significantly lower than those in healthy subjects, and were positively correlated with cognition levels in patients with ischemic stroke. Furthermore, a decrease in serum high-density lipoprotein levels in stroke patients was significantly correlated with a decrease in phosphorylated \u03b1-synuclein levels. Although ischemic stroke mice did not show significant cognitive impairment or disrupted lipid metabolism 14 days after injury, some of them exhibited decreased cognitive function and reduced phosphorylated \u03b1-synuclein levels. Taken together, our results suggest that serum phosphorylated \u03b1-synuclein is a potential biomarker for poststroke cognitive impairment.<\/jats:p>","DOI":"10.4103\/nrr.nrr-d-23-01348","type":"journal-article","created":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T02:02:11Z","timestamp":1717725731000},"page":"2598-2610","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Decreased levels of phosphorylated synuclein in plasma are correlated with poststroke cognitive impairment"],"prefix":"10.4103","volume":"20","author":[{"given":"Yi","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Clinical Laboratory, Beijing Bo\u2019ai Hospital, China Rehabilitation Research Center, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuning","family":"Li","sequence":"additional","affiliation":[{"name":"Beijing Institute of Brain Disorders, Laboratory of Brain Disorders, Ministry of Science and Technology, Collaborative Innovation Center for Brain Disorders, Beijing Advanced Innovation Center for Big Data-based Precision Medicine, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yakun","family":"Gu","sequence":"additional","affiliation":[{"name":"Beijing Institute of Brain Disorders, Laboratory of Brain Disorders, Ministry of Science and Technology, Collaborative Innovation Center for Brain Disorders, Beijing Advanced Innovation Center for Big Data-based Precision Medicine, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Ma","sequence":"additional","affiliation":[{"name":"Beijing Institute of Brain Disorders, Laboratory of Brain Disorders, Ministry of Science and Technology, Collaborative Innovation Center for Brain Disorders, Beijing Advanced Innovation Center for Big Data-based Precision Medicine, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuying","family":"Guan","sequence":"additional","affiliation":[{"name":"Beijing Institute of Brain Disorders, Laboratory of Brain Disorders, Ministry of Science and Technology, Collaborative Innovation Center for Brain Disorders, Beijing Advanced Innovation Center for Big Data-based Precision Medicine, Capital Medical University, Beijing, China"},{"name":"Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyuan","family":"Guo","sequence":"additional","affiliation":[{"name":"Beijing Institute of Brain Disorders, Laboratory of Brain Disorders, Ministry of Science and Technology, Collaborative Innovation Center for Brain Disorders, Beijing Advanced Innovation Center for Big Data-based Precision Medicine, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Shao","sequence":"additional","affiliation":[{"name":"Beijing Institute of Brain Disorders, Laboratory of Brain Disorders, Ministry of Science and Technology, Collaborative Innovation Center for Brain Disorders, Beijing Advanced Innovation Center for Big Data-based Precision Medicine, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xunming","family":"Ji","sequence":"additional","affiliation":[{"name":"Beijing Institute of Brain Disorders, Laboratory of Brain Disorders, Ministry of Science and Technology, Collaborative Innovation Center for Brain Disorders, Beijing Advanced Innovation Center for Big Data-based Precision Medicine, Capital Medical University, Beijing, China"},{"name":"Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6711-3841","authenticated-orcid":false,"given":"Jia","family":"Liu","sequence":"additional","affiliation":[{"name":"Beijing Institute of Brain Disorders, Laboratory of Brain Disorders, Ministry of Science and Technology, Collaborative Innovation Center for Brain Disorders, Beijing Advanced Innovation Center for Big Data-based Precision Medicine, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,6,3]]},"reference":[{"key":"R1-20260427","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nature10324","article-title":"\u03b1-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation","volume":"477","author":"Bartels","year":"2011","journal-title":"Nature"},{"key":"R2-20260427","doi-asserted-by":"crossref","first-page":"102034","DOI":"10.1016\/j.jchemneu.2021.102034","article-title":"Tissue processing and optimal visualization of cerebral infarcts following sub-acute focal ischemia in rats","volume":"118","author":"Bay","year":"2021","journal-title":"J Chem Neuroanat"},{"key":"R3-20260427","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13024-020-00408-1","article-title":"Glycosphingolipids and neuroinflammation in Parkinson\u2019s disease","volume":"15","author":"Belarbi","year":"2020","journal-title":"Mol Neurodegener"},{"key":"R4-20260427","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/jnc.13570","article-title":"The contribution of alpha synuclein to neuronal survival and function -Implications for Parkinson\u2019s disease","volume":"137","author":"Benskey","year":"2016","journal-title":"J Neurochem"},{"key":"R5-20260427","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1038\/nprot.2009.125","article-title":"The adhesive removal test: a sensitive method to assess sensorimotor deficits in mice","volume":"4","author":"Bouet","year":"2009","journal-title":"Nat Protoc"},{"key":"R6-20260427","doi-asserted-by":"crossref","first-page":"E4","DOI":"10.1038\/nature12125","article-title":"Properties of native brain \u03b1-synuclein","volume":"498","author":"Burr\u00e9","year":"2013","journal-title":"Nature"},{"key":"R7-20260427","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s12975-016-0467-5","article-title":"Spontaneous and therapeutic-induced mechanisms of functional recovery after stroke","volume":"8","author":"Cassidy","year":"2017","journal-title":"Transl Stroke Res"},{"key":"R8-20260427","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1161\/STROKEAHA.120.028978","article-title":"Impact of age and sex on \u03b1-Syn (\u03b1-synuclein) knockdown-mediated poststroke recovery","volume":"51","author":"Chelluboina","year":"2020","journal-title":"Stroke"},{"key":"R9-20260427","doi-asserted-by":"crossref","first-page":"885","DOI":"10.3233\/JAD-201038","article-title":"alpha-Synuclein heteromers in red blood cells of alzheimer\u2019s disease and lewy body dementia patients","volume":"80","author":"Daniele","year":"2021","journal-title":"J Alzheimers Dis"},{"key":"R10-20260427","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.2174\/1568026620666200416090820","article-title":"Advances in studies on stroke-induced secondary neurodegeneration (SND) and its treatment","volume":"20","author":"Datta","year":"2020","journal-title":"Curr Top Med Chem"},{"key":"R11-20260427","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1007\/s12975-020-00806-z","article-title":"Cell death pathways in ischemic stroke and targeted pharmacotherapy","volume":"11","author":"Datta","year":"2020","journal-title":"Transl Stroke Res"},{"key":"R12-20260427","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1161\/STROKEAHA.112.670844","article-title":"Prevalence of poststroke cognitive impairment: South London Stroke Register 1995-2010","volume":"44","author":"Douiri","year":"2013","journal-title":"Stroke"},{"key":"R13-20260427","doi-asserted-by":"crossref","first-page":"8825954","DOI":"10.1155\/2020\/8825954","article-title":"Inhibited CSF1R alleviates ischemia injury via inhibition of microglia M1 polarization and NLRP3 pathway","volume":"2020","author":"Du","year":"2020","journal-title":"Neural Plast"},{"key":"R14-20260427","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/1873-3468.12543","article-title":"High-density lipoprotein-like particle formation of Synuclein variants","volume":"591","author":"Eichmann","year":"2017","journal-title":"FEBS Lett"},{"key":"R15-20260427","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1038\/nm.2507","article-title":"Ischemia and reperfusion--from mechanism to translation","volume":"17","author":"Eltzschig","year":"2011","journal-title":"Nat Med"},{"key":"R16-20260427","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s12031-017-0967-0","article-title":"\u03b1-Synuclein interacts with lipoproteins in plasma","volume":"63","author":"Emamzadeh","year":"2017","journal-title":"J Mol Neurosci"},{"key":"R17-20260427","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.molcel.2018.11.028","article-title":"Lipidomic analysis of \u03b1-synuclein neurotoxicity identifies stearoyl CoA desaturase as a target for Parkinson treatment","volume":"73","author":"Fanning","year":"2019","journal-title":"Mol Cell"},{"key":"R18-20260427","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/jnc.14809","article-title":"Parkinson\u2019s disease biomarkers based on \u03b1-synuclein","volume":"150","author":"Fayyad","year":"2019","journal-title":"J Neurochem"},{"key":"R19-20260427","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/ncb748","article-title":"alpha-Synuclein is phosphorylated in synucleinopathy lesions","volume":"4","author":"Fujiwara","year":"2002","journal-title":"Nat Cell Biol"},{"key":"R20-20260427","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1124\/pharmrev.120.000133","article-title":"Therapeutics in the pipeline targeting \u03b1-synuclein for Parkinson\u2019s disease","volume":"74","author":"Grosso Jasutkar","year":"2022","journal-title":"Pharmacol Rev"},{"key":"R21-20260427","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/cns.14055","article-title":"Hypoxic stress accelerates the propagation of pathological alpha-synuclein and degeneration of dopaminergic neurons","volume":"29","author":"Guo","year":"2023","journal-title":"CNS Neurosci Ther"},{"key":"R22-20260427","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/gps.2573","article-title":"High frequency of cognitive dysfunction before stroke among older people","volume":"26","author":"Guti\u00e9rrez P\u00e9rez","year":"2011","journal-title":"Int J Geriatr Psychiatry"},{"key":"R23-20260427","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.jacc.2017.12.006","article-title":"Lipids, Lipoproteins, and Metabolites and Risk of Myocardial Infarction and Stroke","volume":"71","author":"Holmes","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"R24-20260427","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.neulet.2016.01.028","article-title":"Serum miR-132 is a risk marker of post-stroke cognitive impairment","volume":"615","author":"Huang","year":"2016","journal-title":"Neurosci Lett"},{"key":"R25-20260427","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.3233\/JAD-131580","article-title":"Post-stroke cognitive impairment: high prevalence and determining factors in a cohort of mild stroke","volume":"40","author":"Jacquin","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"R26-20260427","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.3390\/biom13081263","article-title":"Alpha-synuclein in peripheral tissues as a possible marker for neurological diseases and other medical conditions","volume":"13","author":"Jim\u00e9nez-Jim\u00e9nez","year":"2023","journal-title":"Biomolecules"},{"key":"R27-20260427","doi-asserted-by":"crossref","first-page":"855","DOI":"10.4103\/1673-5374.382231","article-title":"Pathological and physiological functional cross-talks of \u03b1-synuclein and tau in the central nervous system","volume":"19","author":"Jin","year":"2024","journal-title":"Neural Regen Res"},{"key":"R28-20260427","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.bbadis.2016.01.015","article-title":"Stroke injury, cognitive impairment and vascular dementia","volume":"1862","author":"Kalaria","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"R29-20260427","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.parkreldis.2018.11.016","article-title":"Diagnostic biomarkers for Parkinson\u2019s disease: focus on alpha-synuclein in cerebrospinal fluid","volume":"59","author":"Kalia","year":"2019","journal-title":"Parkinsonism Relat Disord"},{"key":"R30-20260427","doi-asserted-by":"crossref","first-page":"602","DOI":"10.3390\/ijms23020602","article-title":"Potential biomarkers for post-stroke cognitive impairment: a systematic review and meta-analysis","volume":"23","author":"Kim","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R31-20260427","doi-asserted-by":"crossref","first-page":"7055","DOI":"10.1523\/JNEUROSCI.1241-16.2016","article-title":"Poststroke induction of \u03b1-synuclein mediates ischemic brain damage","volume":"36","author":"Kim","year":"2016","journal-title":"J Neurosci"},{"key":"R32-20260427","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13024-021-00501-z","article-title":"Neuropathology and molecular diagnosis of synucleinopathies","volume":"16","author":"Koga","year":"2021","journal-title":"Mol Neurodegener"},{"key":"R33-20260427","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1038\/nprot.2013.155","article-title":"Object recognition test in mice","volume":"8","author":"Leger","year":"2013","journal-title":"Nat Protoc"},{"key":"R34-20260427","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/cns.13996","article-title":"Intermittent hypoxic conditioning restores neurological dysfunction of mice induced by long-term hypoxia","volume":"29","author":"Li","year":"2023","journal-title":"CNS Neurosci Ther"},{"key":"R35-20260427","doi-asserted-by":"crossref","first-page":"650","DOI":"10.4103\/1673-5374.380906","article-title":"Astrocytic endothelin-1 overexpression impairs learning and memory ability in ischemic stroke via altered hippocampal neurogenesis and lipid metabolism","volume":"19","author":"Li","year":"2024","journal-title":"Neural Regen Res"},{"key":"R36-20260427","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1017\/cjn.2018.56","article-title":"Stroke and coronary artery disease are associated with Parkinson\u2019s disease","volume":"45","author":"Li","year":"2018","journal-title":"Can J Neurol Sci"},{"key":"R37-20260427","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1007\/s12031-020-01524-9","article-title":"Association between stroke and Parkinson\u2019s disease: a meta-analysis","volume":"70","author":"Liu","year":"2020","journal-title":"J Mol Neurosci"},{"key":"R38-20260427","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3389\/fnagi.2017.00233","article-title":"Curcumin protects against ischemic stroke by titrating microglia\/macrophage polarization","volume":"9","author":"Liu","year":"2017","journal-title":"Front Aging Neurosci"},{"key":"R39-20260427","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1126\/science.1227157","article-title":"Pathological \u03b1-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice","volume":"338","author":"Luk","year":"2012","journal-title":"Science"},{"key":"R40-20260427","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.4103\/1673-5374.389303","article-title":"High-frequency repetitive transcranial magnetic stimulation promotes neural stem cell proliferation after ischemic stroke","volume":"19","author":"Luo","year":"2024","journal-title":"Neural Regen Res"},{"key":"R41-20260427","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3233\/JAD-2011-110221","article-title":"Autoantibodies against amyloid and glial-derived antigens are increased in serum and cerebrospinal fluid of Lewy body-associated dementias","volume":"26","author":"Maetzler","year":"2011","journal-title":"J Alzheimers Dis"},{"key":"R42-20260427","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s40035-020-00192-4","article-title":"CSF total and oligomeric \u03b1-Synuclein along with TNF-\u03b1 as risk biomarkers for Parkinson\u2019s disease: a study in LRRK2 mutation carriers","volume":"9","author":"Majbour","year":"2020","journal-title":"Transl Neurodegener"},{"key":"R43-20260427","first-page":"105","article-title":"Applications of fractal analysis techniques in magnetic resonance imaging and computed tomography for stroke diagnosis and stroke-related brain damage: a narrative review","volume":"1","author":"Maryenko","year":"2024","journal-title":"Adv Technol Neurosci"},{"key":"R44-20260427","doi-asserted-by":"crossref","first-page":"e011699","DOI":"10.1161\/JAHA.118.011699","article-title":"Neurobehavioral deficits after subarachnoid hemorrhage in mice: sensitivity analysis and development of a new composite score","volume":"8","author":"Matsumura","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"R45-20260427","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s12975-021-00981-7","article-title":"MicroRNA miR-7 is essential for post-stroke functional recovery","volume":"14","author":"Mehta","year":"2023","journal-title":"Transl Stroke Res"},{"key":"R46-20260427","first-page":"2261","article-title":"Dementia after stroke: high incidence and intriguing associations","volume":"33","author":"Merino","year":"2002","journal-title":"Stroke"},{"key":"R48-20260427","first-page":"e12070","article-title":"Peri-arterial pathways for clearance of alpha-Synuclein and tau from the brain: Implications for the pathogenesis of dementias and for immunotherapy","volume":"12","author":"Nimmo","year":"2020","journal-title":"Alzheimers Dement (Amst)"},{"key":"R49-20260427","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.1007\/s00415-020-09985-z","article-title":"Early autonomic and cognitive dysfunction in PD, DLB and MSA: blurring the boundaries between \u03b1-synucleinopathies","volume":"267","author":"Palermo","year":"2020","journal-title":"J Neurol"},{"key":"R50-20260427","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S1474-4422(19)30024-9","article-title":"CSF and blood biomarkers for Parkinson\u2019s disease","volume":"18","author":"Parnetti","year":"2019","journal-title":"Lancet Neurol"},{"key":"R51-20260427","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1191\/0269215503cr596oa","article-title":"Natural history of cognitive impairment after stroke and factors associated with its recovery","volume":"17","author":"Patel","year":"2003","journal-title":"Clin Rehabil"},{"key":"R52-20260427","doi-asserted-by":"crossref","first-page":"e3000410","DOI":"10.1371\/journal.pbio.3000410","article-title":"The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research","volume":"18","author":"Percie du Sert","year":"2020","journal-title":"PLoS Biol"},{"key":"R54-20260427","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1161\/STROKEAHA.111.680728","article-title":"Baseline cognitive function, recurrent stroke, and risk of dementia in patients with stroke","volume":"44","author":"Rist","year":"2013","journal-title":"Stroke"},{"key":"R55-20260427","doi-asserted-by":"crossref","first-page":"16884","DOI":"10.1523\/JNEUROSCI.3967-11.2011","article-title":"Authentically phosphorylated \u03b1-synuclein at Ser129 accelerates neurodegeneration in a rat model of familial Parkinson\u2019s disease","volume":"31","author":"Sato","year":"2011","journal-title":"J Neurosci"},{"key":"R56-20260427","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat Methods"},{"key":"R57-20260427","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-019-01977-2","article-title":"alpha-Synuclein and astrocytes: tracing the pathways from homeostasis to neurodegeneration in Lewy body disease","volume":"138","author":"Sorrentino","year":"2019","journal-title":"Acta Neuropathol"},{"key":"R58-20260427","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.expneurol.2015.03.021","article-title":"White matter injury and microglia\/macrophage polarization are strongly linked with age-related long-term deficits in neurological function after stroke","volume":"272","author":"Suenaga","year":"2015","journal-title":"Exp Neurol"},{"key":"R59-20260427","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1002\/mds.26290","article-title":"Plasma apolipoprotein A1 associates with age at onset and motor severity in early Parkinson\u2019s disease patients","volume":"30","author":"Swanson","year":"2015","journal-title":"Mov Disord"},{"key":"R60-20260427","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/nri.2017.103","article-title":"Regulation of immunity and inflammation by hypoxia in immunological niches","volume":"17","author":"Taylor","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"R61-20260427","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.archger.2013.09.006","article-title":"The current situation on vascular cognitive impairment after ischemic stroke in Changsha","volume":"58","author":"Tu","year":"2014","journal-title":"Arch Gerontol Geriatr"},{"key":"R62-20260427","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/jnc.14713","article-title":"Antibodies against alpha-synuclein: tools and therapies","volume":"150","author":"Vaikath","year":"2019","journal-title":"J Neurochem"},{"key":"R63-20260427","first-page":"1134","article-title":"Association of diagnostic stroke biomarkers with post stroke cognitive impairment","volume":"6","author":"Wahul","year":"2018","journal-title":"J Neurol Disord Stroke"},{"key":"R64-20260427","doi-asserted-by":"crossref","first-page":"571437","DOI":"10.3389\/fnagi.2020.571437","article-title":"Differential circulating levels of naturally occurring antibody to \u03b1-synuclein in Parkinson\u2019s disease dementia, Alzheimer\u2019s disease, and vascular dementia","volume":"12","author":"Wang","year":"2020","journal-title":"Front Aging Neurosci"},{"key":"R65-20260427","doi-asserted-by":"crossref","first-page":"e931601","DOI":"10.12659\/MSM.931601","article-title":"Effects of repetitive transcranial magnetic stimulation (rTMS) and treadmill training on recovery of motor function in a rat model of partial spinal cord injury","volume":"27","author":"Wang","year":"2021","journal-title":"Med Sci Monit"},{"key":"R66-20260427","article-title":"Decreased levels of phosphorylated synuclein in plasma are correlated with poststroke cognitive impairment","author":"Wang","year":"2024","journal-title":"Neural Regen Res"},{"key":"R67-20260427","doi-asserted-by":"crossref","first-page":"631738","DOI":"10.3389\/fnagi.2021.631738","article-title":"Plasma neurofilament light chain as a predictive biomarker for post-stroke cognitive impairment: a prospective cohort study","volume":"13","author":"Wang","year":"2021","journal-title":"Front Aging Neurosci"},{"key":"R68-20260427","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3389\/fnins.2020.00215","article-title":"MicroRNA Let-7i is a promising serum biomarker for post-stroke cognitive impairment and alleviated OGD-induced cell damage in vitro by regulating Bcl-2","volume":"14","author":"Wang","year":"2020","journal-title":"Front Neurosci"},{"key":"R69-20260427","first-page":"1757","article-title":"Alpha-synuclein alterations in red blood cells of peripheral blood after acute ischemic stroke","volume":"12","author":"Wu","year":"2019","journal-title":"Int J Clin Exp Pathol"},{"key":"R70-20260427","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.4103\/1673-5374.387967","article-title":"\u03b1-Synuclein pathology from the body to the brain: so many seeds so close to the central soil","volume":"19","author":"Yang","year":"2024","journal-title":"Neural Regen Res"},{"key":"R71-20260427","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s10072-016-2485-1","article-title":"A comparative study of the amount of alpha-synuclein in ischemic stroke and Parkinson\u2019s disease","volume":"37","author":"Zhao","year":"2016","journal-title":"Neurol Sci"},{"key":"R72-20260427","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.neuroscience.2021.06.033","article-title":"Investigation of \u03b1-synuclein species in plasma exosomes and the oligomeric and phosphorylated \u03b1-synuclein as potential peripheral biomarker of Parkinson\u2019s disease","volume":"469","author":"Zheng","year":"2021","journal-title":"Neuroscience"}],"container-title":["Neural Regeneration Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/NRR.NRR-D-23-01348","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:44:11Z","timestamp":1787067851000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/NRR.NRR-D-23-01348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,3]]},"references-count":70,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/nrr.nrr-d-23-01348","relation":{},"ISSN":["1673-5374","1876-7958"],"issn-type":[{"value":"1673-5374","type":"print"},{"value":"1876-7958","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,3]]},"assertion":[{"value":"2023-08-12","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-02-29","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}